(LYQS) Amundi IS Global EmBdMrkt - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Etf •
ISIN: LU1686830909
Bonds, Emerging Markets, Sovereign Debt, Government Securities
Description: LYQS Amundi IS Global EmBdMrkt
URL: http://www.amundi.com Index: Morningstar EM Sov Bd GR USD
Additional Sources for LYQS ETF
LYQS ETF Overview
| Market Cap in USD | 124m |
| Category | Global Emerging Markets Bond |
| TER | 0.30% |
| IPO / Inception | 2024-02-08 |
LYQS ETF Ratings
| Growth Rating | -42.0 |
| Fundamental | - |
| Dividend Rating | 10.2 |
| Rel. Strength | -4.22 |
| Analysts | - |
| Fair Price Momentum | 60.82 EUR |
| Fair Price DCF | - |
LYQS Dividends
Currently no dividends paidLYQS Growth Ratios
| Growth Correlation 3m | 17.7% |
| Growth Correlation 12m | -60.6% |
| Growth Correlation 5y | -59.5% |
| CAGR 5y | -2.34% |
| CAGR/Max DD 5y | -0.12 |
| Sharpe Ratio 12m | -0.11 |
| Alpha | -11.68 |
| Beta | 0.102 |
| Volatility | 92.39% |
| Current Volume | 0.2k |
| Average Volume 20d | 0.2k |
What is the price of LYQS shares?
As of July 06, 2025, the stock is trading at EUR 66.99 with a total of 150 shares traded.
Over the past week, the price has changed by +0.47%, over one month by -0.83%, over three months by -3.37% and over the past year by -6.16%.
As of July 06, 2025, the stock is trading at EUR 66.99 with a total of 150 shares traded.
Over the past week, the price has changed by +0.47%, over one month by -0.83%, over three months by -3.37% and over the past year by -6.16%.
Is Amundi IS Global EmBdMrkt a good stock to buy?
Probably not. Based on ValueRay´s Analyses, Amundi IS Global EmBdMrkt (XETRA:LYQS) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -41.99 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYQS is around 60.82 EUR . This means that LYQS is currently overvalued and has a potential downside of -9.21%.
Probably not. Based on ValueRay´s Analyses, Amundi IS Global EmBdMrkt (XETRA:LYQS) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -41.99 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYQS is around 60.82 EUR . This means that LYQS is currently overvalued and has a potential downside of -9.21%.
Is LYQS a buy, sell or hold?
Amundi IS Global EmBdMrkt has no consensus analysts rating.
Amundi IS Global EmBdMrkt has no consensus analysts rating.
What are the forecasts for LYQS share price target?
According to our own proprietary Forecast Model, LYQS Amundi IS Global EmBdMrkt will be worth about 65.7 in July 2026. The stock is currently trading at 66.99. This means that the stock has a potential downside of -1.88%.
According to our own proprietary Forecast Model, LYQS Amundi IS Global EmBdMrkt will be worth about 65.7 in July 2026. The stock is currently trading at 66.99. This means that the stock has a potential downside of -1.88%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 65.7 | -1.9% |